Lv41
770 积分 2026-02-25 加入
Relapsed/Refractory T- Acute Lymphoblastic Leukemia — Current Options and Future Directions
15天前
已完结
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
1个月前
已完结
Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
1个月前
已完结
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
1个月前
已完结
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies
1个月前
已完结
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
2个月前
已完结
New insights into TCR β-selection
2个月前
已完结
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia/lymphoma: challenges, opportunities, and future directions
3个月前
已完结
Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia
3个月前
已完结
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia
3个月前
已完结
皖公网安备34019202002308
